Improved survival trends in platinum-resistant patients with advanced ovarian, fallopian or peritoneal cancer treated with first-line paclitaxel/platinum chemotherapy: The impact of novel agents-论文-万方医学网

首页> > Improved survival trends in platinum-resistant patients with advanced ovarian, fallopian or peritoneal cancer treated with first-line paclitaxel/platinum chemotherapy: The impact of novel agents

Improved survival trends in platinum-resistant patients with advanced ovarian, fallopian or peritoneal cancer treated with first-line paclitaxel/platinum chemotherapy: The impact of novel agents

导出原文传递

翻译打印收藏纠错

第一作者： Bamias,A.

作者： Bamias,A. ^[1] ; Bamia,C. ^[2] ; Zagouri,F. ^[3] ; Kostouros,E. ; Kakoyianni,K. ; Rodolakis,A. ; Vlahos,G. ; Haidopoulos,D. ; Thomakos,N. ; Antsaklis,A. ; Dimopoulos,M.-A.

作者单位： Departments of Clinical Therapeutics, Oncology Unit, 80 Vas. Sofias Ave., GR-115 28 Athens, Greece ^[1] Departments of Hygiene and Epidemiology, Greece ^[2] Departments of Obstetrics and Gynaecology, University of Athens, Athens, Greece ^[3]

关键词 Chemotherapy Ovarian cancer Platinum-resistant

发布时间 2022-10-27

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

法律状态公告日	法律状态	法律状态信息

检索历史清除

Improved survival trends in platinum-resistant patients with advanced ovarian, fallopian or peritoneal cancer treated with first-line paclitaxel/platinum chemotherapy: The impact of novel agents

相似文献

同项目论文

相关期刊

检索历史 清除

Improved survival trends in platinum-resistant patients with advanced ovarian, fallopian or peritoneal cancer treated with first-line paclitaxel/platinum chemotherapy: The impact of novel agents

相似文献

同项目论文

相关期刊

检索历史清除